← Back to Search

Multimodal Teleprehabilitation for Abdominal Cancer

N/A
Waitlist Available
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, for an expected duration of of 1.5 year.
Awards & highlights

Study Summary

This trial aims to deliver a prehabilitation program to all cancer patients scheduled for surgery at the MUHC, addressing the patients' risk factors in patients' pandemic reality perspective.

Eligible Conditions
  • Abdominal Cancer
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, for an expected duration of of 1.5 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, for an expected duration of of 1.5 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Intervention-Related Adverse Events
Program Completion Rate
+5 more
Secondary outcome measures
2- or 6-Minute Walk Test
30 Second Sit-to-Stand
Abridged-Scored Patient-Generated Subjective Global Assessment (PG-SGA)
+16 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Teleprehabilitation cohortExperimental Treatment1 Intervention
Patients in this single-arm study will receive multimodal teleprehabilitation.

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
443 Previous Clinical Trials
159,398 Total Patients Enrolled
Montreal General HospitalOTHER
17 Previous Clinical Trials
9,937 Total Patients Enrolled
Peri Operative Program, MontrealUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the principal intent of this experiment?

"This clinical trial, lasting a period of 1.5 years and evaluated through study completion, hopes to evaluate primary outcomes such as drop-outs for rational analysis. Secondary objectives encompass the WHO Disability Assessment Schedule v2.0 (WHODAS) to measure disability free survival at specific intervals, Body Mass Index (BMI), ranging from 18 - 30 with anything above 30 considered obesity and below 18 malnourished, and The 30-day Mortality which counts the number of deaths within a month post-surgery."

Answered by AI

Is it possible to enrol in this investigation at the present time?

"Affirmative. The clinical trial's listing on clinicaltrials.gov confirms that recruitment is in progress; it was originally posted on March 12th 2021 and the last update occurred September 24th 2021. A total of 100 individuals are being sought to join this research at one particular site."

Answered by AI

How many participants are currently engaged in this clinical experiment?

"Affirmative. Data on clinicaltrials.gov suggests that this medical research, which was initially uploaded on March 12th 2021 is actively recruiting patients to participate in the study. Approximately 100 individuals are needed at 1 different sites for completion of the trial."

Answered by AI
~24 spots leftby Apr 2025